Table 5.

Long-term outcomes in mesangial IgG nephropathya

Patient No.Follow-Up Period (yr)HP (g/d)BP (mmHg)SCr (μM)CrCl (ml/min)
a Patients 3, 5, 6, and 10 were lost to follow-up monitoring. H, microscopic hematuria; P, proteinuria; SCr, serum creatinine concentration; CrCl, creatinine clearance; ESRD, end-stage renal disease.
b With antihypertensive therapy.
c Underwent two consecutive renal transplantations.
120+2.3150 /100b9960
27+5.3150 /80bESRDESRD
41511.7140 /100bESRDESRDc
7230.45110 /90b15057
825125 /8081115
912+1.4145 /96a7078
116+10120 /80b18040
1243.4140 /90ESRDESRDc
1330.5150 /90ESRDESRD
147+2132 /8082124